Browse 710 respiratory clinical trials enrolling across the United States and Canada. 383 people applied to respiratory studies last month. Search by city or state to find one near you.
Filter
1
Filter results
Results: 710
MRG-001 as an Immunoregulatory and Regenerative Therapy for COVID-19 Patients
for
COVID-19, ARDS, Human, Stem Cells, Regeneration
Location: Baltimore MD
Sponsor: MedRegen LLC
Sex: All
Age: 18+
Code: NCT04646603
Phase2, Recruiting
An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or Biopsy
Study to Evaluate ARINA-1 in the Prevention of Bronchiolitis Obliterans Progression in Participants With Bilateral Lung Transplant
for
Pre-Bronchiolitis Obliterans Syndrome
Location: New York NY, Philadelphia PA, Baltimore MD,
Sponsor: Renovion, Inc.
Sex: All
Age: 18 - 70+
Code: NCT05654922
Phase3, Recruiting
POC Study to Evaluate the Performance of the AcuVid COVID-19 Rapid Antigen Saliva Test
for
COVID-19
Location: Modesto CA
Sponsor: Therma Bright Inc
Sex: All
Age: 12+
Code: NCT05119530
Recruiting
Comparing Intubation Rates in the Delivery Room by Interface
for
Ventilator Lung; Newborn
Location: Peoria IL
Sponsor: University of Illinois College of Medicine at Peoria
Sex: All
Age: 0
Code: NCT05609773
Recruiting
Hyperinflation Respiratory Therapies in Cardiac Surgery Patients
for
Pulmonary Disease, Postoperative Complications
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center
Sex: All
Age: 18 - 70+
Code: NCT04164173
Recruiting
A Study Evaluating MDX2301 in Healthy Adults and Adults at Higher Risk for Severe COVID-19.
for
COVID -19, COVID-19 (Prevention)
Location: Austin TX, Las Vegas NV
Sponsor: ModeX Therapeutics, An OPKO Health Company
Sex: All
Age: 18 - 64
Code: NCT07445971
Phase1, Recruiting
A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations
for
SARS-CoV-2
Location: Richmond VA, Decatur GA, Atlanta GA, Gulfport MS,
Sponsor: ModernaTX, Inc.
Sex: All
Age: 0+
Code: NCT06585241
Recruiting
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
for
Chronic Obstructive Pulmonary Disease
Location: Boston MA, Flushing NY, East Orange NJ, Philadelphia PA,
Sponsor: Sanofi
Sex: All
Age: 40 - 70+
Code: NCT07190209
Phase3, Recruiting
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
for
Chronic Obstructive Pulmonary Disease
Location: New Bedford MA, Quebec, Victoriaville, Trois-Rivieres,